Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI ... enzymes and therefore is associated with few drug interactions other than metformin and dofetilide. Dolutegravir should ...

HIV drugs have revolutionized the management ... which is expected to reach US$29 Billion by 2030 with a CAGR of a 5.2%. The Integrase Inhibitors (INIs) segment is also set to grow at 5.7% CAGR ...

The HIV treatment landscape has further evolved with the introduction of LAI therapies, offering alternatives to daily oral ...

Angiotensin-converting enzyme (ACE) inhibitors are oral medications that lower blood pressure. They are used to treat a variety of heart-related conditions including high blood pressure, coronary ...

The dispute centred around Gilead's triple-drug regimen Biktarvy, which is based on emtricitabine, tenofovir alafenamide and integrase inhibitor bictegravir. ViiV claimed the latter compound ...

The Food and Drug Administration (FDA ... NS-229 is an investigational selective Janus kinase 1 (JAK1) inhibitor designed to prevent tissue damage caused by EGPA by suppressing immune cell ...

In their paper, the team concluded that revealing the binding poses of three major inhibitor classes will allow “… further exploration of MPC as a drug target for treating diabetes mellitus ...

2 Patients who have taken pre-exposure prophylaxis drugs and have suspected recent HIV acquisition might present ... Dual oral treatment is also increasingly common, such as a nucleoside reverse ...